140
Views
6
CrossRef citations to date
0
Altmetric
Miscellaneous

Candesartan for the prevention and treatment of stroke – results of the SCOPE and ACCESS trials

Pages 687-690 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexander Joost, Heribert Schunkert & Peter Walter Radke. (2011) Candesartan cilexetil: an update. Expert Opinion on Pharmacotherapy 12:11, pages 1769-1780.
Read now

Articles from other publishers (5)

Yubao Ding, Yue Lang, Hui Zhang, Yu Li, Xiao Liu & Minjie Li. (2022) Candesartan Reduces Neuronal Apoptosis Caused by Ischemic Stroke via Regulating the FFAR1/ITGA4 Pathway. Mediators of Inflammation 2022, pages 1-14.
Crossref
Saiqa Yasmeen, Bilal Hussain Akram, Atticus H. Hainsworth & Christina Kruuse. (2019) Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review. Cellular Signalling 61, pages 108-119.
Crossref
Poornima Venkat, Yi Shen, Michael Chopp & Jieli Chen. (2018) Cell-based and pharmacological neurorestorative therapies for ischemic stroke. Neuropharmacology 134, pages 310-322.
Crossref
Hyun Ju YoonKye Hun Kim. (2012) Current Issues on the Angiotensin II Receptor Blocker in Cardiovascular Disease. Journal of the Korean Society of Hypertension 18:1, pages 17.
Crossref
Hiromichi SUZUKI & Yoshihiko KANNO. (2005) Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients. Hypertension Research 28:4, pages 307-314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.